SOL SOLACI Performed a New Intervention During the Ecuador Sessions 2020

A new charitable case was featured at the Ecuador XL SOLACI Sessions 2020. At the CardioCentro Manta / Angiomanabí Clinic in Manta, Ecuador, physicians performed a successful closure of ductus arteriosus type A1 with an Amplatzer ADO I device (antegrade access). The patient was a 1-year old child admitted with a diagnosis of persistent ductus arteriosus. The case was sponsored by C.G MED.

Thus, SOLACI’s SOLidario (which means ‘solidary’ in Spanish) Program continues with its mission: facilitating the access to percutaneous and/or cardiovascular procedures to Latin American patients without the medical coverage or economic resources for them.

Below, the case presentation during the Ecuador Sessions 2020.

caso-solidario-jornadas-ecuador-2020

SOLACI’s SOLidario Program Against the COVID-19 Pandemic

Today, more than ever, the members of SOLACI’s SOLidario Program want our Latin American colleagues to know that we are in this together. As everyone knows, the primary purpose of this program is to grant our patients access to interventional procedures in renowned medical centers. Specialists who are SOLACI members perform such interventions in collaboration with other internationally famed experts.

The current situation would have been hard to imagine a short time ago. This pandemic represents an unimaginable challenge, but we will work together so that we can lead the resistance against the disease, directing our best efforts to aid those most vulnerable.

Dr. Marcelo Halac.
Head of SOLACI’s SOLidario Program.


About SOL SOLACI

programa solidario solaci

SOLACI’s SOLidario Program is a facilitator connecting the patient, the institution, the local scientific community, and the specialist with local suppliers in each country so that the performing team can count with the adequate supply of elements, drugs, and/or endovascular devices for a successful procedure.

Created by a group of adult and pediatric interventional cardiologists who are SOLACI members, SOLACI SOL seeks to facilitate the access to percutaneous therapeutic and diagnostic cardiovascular procedures, conducted in renowned medical centers by specialists who are SOLACI members, to patients in Latin America and the Caribbean who lack the medical coverage or economic resources for them.

In case of questions about SOLACI’s SOLidario Program, contact us at jornadas@solaci.org


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Check out the best images of the El Salvador 2024 Sessions

Review the highlights of the XLIX SOLACI Regional Sessions held at the Intercontinental Hotel in San Salvador, El Salvador between November 7 and 8,...

The El Salvador 2024 Sessions are coming soon

The XLIX SOLACI 2024 Regional Sessions (17th Central America & the Caribbean) are approaching, and will take place in the city of San Salvador (El Salvador)....

Check out the best images of the Arequipa 2024 Sessions

Review the highlights of the XVIII SOLACI Regional Sessions held at the Hanan Hotel in Arequipa, Peru between October 3 and 4, 2024. <!-- wp:tw/bwg...

Virtual Event SOLACI-Medtronic | The Visible Heart Lab

We invite you to participate in a new virtual activity organized in collaboration with Medtronic, focused on "The Visible Heart Lab" and dedicated to...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....